Origenis

Origenis is a contract research organisation offering services in drug design, synthesis, and characterisation.

Origenis provides small molecule drug discovery services. It offers drug design, chemical synthesis, and biological characterization services combined with its proprietary small molecule drug discovery technology platform. Its technology platforms include MOREsystem and MolMind which provide direct exploitation of huge chemical spaces and delivers straightforward synthetic routes generating patentable drug candidates in less time.